Friday, April 09, 2021 10:14:40 AM
New York Yankees and Duke Basketball
Recent RPHM News
- Kuehn Law Encourages INFN, RPHM, VAPO, and PRFT Investors to Contact Law Firm • PR Newswire (US) • 07/01/2024 07:13:00 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/13/2024 01:38:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 01:14:11 PM
- Reneo Pharmaceuticals and OnKure Announce Proposed Merger • GlobeNewswire Inc. • 05/13/2024 11:35:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:03:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:00:15 PM
- Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/07/2024 11:35:00 AM
- Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update • GlobeNewswire Inc. • 03/28/2024 11:35:00 AM
- Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors • GlobeNewswire Inc. • 03/25/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:00:15 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/05/2024 09:01:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 02:26:00 PM
- Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM) • GlobeNewswire Inc. • 12/14/2023 02:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/22/2023 05:15:05 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/13/2023 10:08:12 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/13/2023 09:58:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:05:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:00:11 PM
- Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results • GlobeNewswire Inc. • 11/13/2023 12:35:00 PM
- Reneo Pharmaceuticals to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 11/02/2023 11:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:47:24 PM
- Reneo Pharmaceuticals Announces Poster Presentation at Upcoming Scientific Meetings • GlobeNewswire Inc. • 10/25/2023 11:50:00 AM
- Reneo Pharmaceuticals Announces Last Patient Last Visit in the Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM) • GlobeNewswire Inc. • 10/09/2023 11:50:00 AM
- Reneo Pharmaceuticals to Participate in the Jefferies Biotech CNS/Neuro Summit • GlobeNewswire Inc. • 10/06/2023 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/29/2023 09:04:03 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM